ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
advertisementadvertisement
Cytokine
Volume 30, Issue 6, 21 June 2005, Pages 339-346
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (235 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.cyto.2005.01.002    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2005 Elsevier Ltd All rights reserved.

Interleukin-1-deficient mice exhibit high sensitivity to gut-derived sepsis caused by Pseudomonas aeruginosa

Tetsuya Horinoa, Tetsuya Matsumotob, Corresponding Author Contact Information, E-mail The Corresponding Author, Masashi Uramatsub, Masaaki Tanabeb, Kazuhiro Tatedab, Shuichi Miyazakib, Akio Nakanec, Yoichiro Iwakurad and Keizo Yamaguchib

aDepartment of Internal Medicine, Jikei University School of Medicine, Nishi-Shimbashi, Minato-ku, Tokyo, Japan bDepartment of Microbiology, Toho University School of Medicine, 5-21-16 Omori-Nishi, Ota-ku, Tokyo 143-8540, Japan cDepartment of Bacteriology, Hirosaki University School of Medicine, Zaifu-cho, Hirosaki, Aomori, Japan dLaboratory Animal Research Center, Institute of Medical Science, University of Tokyo, Tokyo, Japan

Received 5 January 2004; 
revised 20 October 2004; 
accepted 4 January 2005. 
Available online 2 April 2005.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

Background

The role of interleukin (IL)-1 in infectious diseases is controversial; some investigators indicated an enhancing effect of IL-1 on host resistance whereas others demonstrated the protective role of IL-1 receptor antagonist in infection. We evaluated the role of endogenous IL-1 in gut-derived sepsis caused by Pseudomonas aeruginosa, by comparing IL-1-deficient mice and wild-type (WT) mice.

Methods

Gut-derived sepsis was induced by intraperitoneal injection of cyclophosphamide after colonization of P. aeruginosa strain D4 in the intestine.

Results

The survival rate of IL-1-deficient mice was significantly lower than that of WT mice (P < 0.01). Bacterial counts in the liver, mesenteric lymph node and blood were significantly higher in IL-1-deficient mice than in WT mice. Tumor necrosis factor alpha and IL-6 in the liver were significantly higher in IL-1-deficient mice than in WT mice. In vitro, phagocytosis and cytokine production by macrophages were impaired in IL-1-deficient mice compared with WT mice.

Conclusion

Our results indicate a critical role for IL-1 during gut-derived P. aeruginosa sepsis. The results also suggest that both impairment of cytokine production and phagocytosis by macrophages are caused by IL-1 deficiency and lead to impaired host response.

Keywords: Interleukin-1; Pseudomonas aeruginosa; Sepsis; Bacterial translocation

Article Outline

1. Introduction
2. Results
2.1. Increased mortality of IL-1-deficient mice following gut-derived sepsis caused by P. aeruginosa
2.2. Viable bacteria counts in body organs
2.3. Cytokines production during gut-derived sepsis
2.4. Effect of cyclophosphamide on peripheral blood leukocyte count
2.5. Role of TNF-α on survival of IL-1-deficient mice
2.6. Impaired phagocytic activity of murine peritoneal macrophages of IL-1-deficient mice
2.7. Downregulation of cytokine production by peritoneal macrophages after bacterial stimulation in IL-1-deficient mice
3. Discussion
4. Materials and methods
4.1. Animals
4.2. Bacterial strain
4.3. Reagents
4.4. Murine gut-derived sepsis with P. aeruginosa
4.5. Determination of viable bacteria in organs
4.6. Role of IL-1 on phagocytic activity of murine peritoneal macrophages
4.7. Cytokine analysis
4.8. Statistical analysis
References







Cytokine
Volume 30, Issue 6, 21 June 2005, Pages 339-346
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.